Pharmaceutical

Ocular Therapeutix gets grant for intracanalicular injectable applicator device for drug delivery

Discover Ocular Therapeutix's patented intracanalicular injectable device, designed for precise delivery of treatments through the lacrimal punctum. Explore its innovative features!

Aug 23, 2024 - 04:00
Discover Ocular Therapeutix's patented intracanalicular injectable device, designed for precise delivery of treatments through the lacrimal punctum. Explore its innovative features!
Read the original article

Tags:

Previous Article

Orion gets grant for cyp11a1 inhibitors for treating prostate cancer

Next Article

Aquestive Therapeutics gets grant for enhanced pharmaceutical compositions for a...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Formation Bio secures $372m funds for AI-driven drug platform

Formation Bio secures $372m funds for AI-driven drug pl...

Jun 28, 2024

Launching pharmaceuticals in Belgium, the Netherlands, and Luxembourg: Opportunities and challenges

Launching pharmaceuticals in Belgium, the Netherlands, ...

Sep 21, 2023

STAT+: AI health care companies say they’ll keep humans in the loop. But what does that actually mean?

STAT+: AI health care companies say they’ll keep humans...

Mar 13, 2024